Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARA | P10276 | 8/20 | 0.37 |
| ▸ | RARB | P10826 | 7/20 | 0.37 |
| ▸ | RARG | P13631 | 6/20 | 0.37 |
| ▸ | RXRA | P19793 | 10/20 | 0.35 |
| ▸ | RXRB | P28702 | 6/20 | 0.35 |
| ▸ | RXRG | P48443 | 6/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26308240 | 1.00 | RARA (0.37) | RARARARBRARGRXRARXRB | |
| SCHEMBL29331177 | 0.90 | ALOX5 (0.43) | RARARARBRARGRXRARXRB | |
| SCHEMBL29331174 | 0.90 | ALOX5 (0.43) | RARARARBRARGRXRARXRB | |
| SCHEMBL29331328 | 0.88 | RARA (0.37) | RARARARBRARGRXRARXRB | |
| SCHEMBL26303499 | 0.88 | RARA (0.37) | RARARARBRARGRXRARXRB | |
| SCHEMBL26303718 | 0.88 | RARA (0.37) | RARARARBRARGRXRARXRB | |
| SCHEMBL24771788 | 0.88 | MEN1 (0.31) | RXRARXRBRXRGMEN1CYP2C19 | |
| SCHEMBL26304257 | 0.87 | ALOX5 (0.41) | RARARARBRARGRXRARXRB | |
| SCHEMBL29331150 | 0.86 | RXRA (0.38) | RARARARBRARGRXRARXRB | |
| SCHEMBL29331326 | 0.86 | RXRA (0.38) | RARARARBRARGRXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12048240-B2 | Organic compound, electronic component and electronic apparatus comprising the same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-07-23 | — | — | US | disclosed |
| US-12048240-B2 | Organic compound, electronic component and electronic apparatus comprising the same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12048240-B2 | Organic compound, electronic component and electronic apparatus comprising the same | PIEZO1, OCIAD1, OSTC | RARA 1944/4885RARB 2554/4885RARG 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.